338 related articles for article (PubMed ID: 32068334)
1. Testosterone replacement therapy.
Barbonetti A; D'Andrea S; Francavilla S
Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
[TBL] [Abstract][Full Text] [Related]
2. Late-onset hypogonadism: a concept comes of age.
Nieschlag E
Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of testosterone replacement therapy preparations.
Shoskes JJ; Wilson MK; Spinner ML
Transl Androl Urol; 2016 Dec; 5(6):834-843. PubMed ID: 28078214
[TBL] [Abstract][Full Text] [Related]
4. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
[TBL] [Abstract][Full Text] [Related]
5. Late-onset Hypogonadism: Bone health.
Rochira V
Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
[TBL] [Abstract][Full Text] [Related]
6. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
7. Late-onset hypogonadism: Prostate safety.
Miranda EP; Torres LO
Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
[TBL] [Abstract][Full Text] [Related]
8. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
10. Critical evaluation of different available guidelines for late-onset hypogonadism.
Giagulli VA; Castellana M; Lisco G; Triggiani V
Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
Ko YH; Kim JJ
Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?
Awouters M; Vanderschueren D; Antonio L
Andrology; 2020 Nov; 8(6):1590-1597. PubMed ID: 31696669
[TBL] [Abstract][Full Text] [Related]
13. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
14. Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.
Nightingale TE; Moore P; Harman J; Khalil R; Gill RS; Castillo T; Adler RA; Gorgey AS
J Spinal Cord Med; 2018 Nov; 41(6):624-636. PubMed ID: 28770686
[TBL] [Abstract][Full Text] [Related]
15. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
16. Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy.
Bauman WA; La Fountaine MF; Cirnigliaro CM; Kirshblum SC; Spungen AM
J Spinal Cord Med; 2015 Jan; 38(1):38-47. PubMed ID: 24968251
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
[TBL] [Abstract][Full Text] [Related]
18. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.
Skinner JW; Otzel DM; Bowser A; Nargi D; Agarwal S; Peterson MD; Zou B; Borst SE; Yarrow JF
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):465-481. PubMed ID: 29542875
[TBL] [Abstract][Full Text] [Related]
19. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
[TBL] [Abstract][Full Text] [Related]
20. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]